Resnick, I B <br/><br/>
Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen.  [electronic resource] 

 -  Bone marrow transplantation  Nov 2007 
 - 957-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1705826  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antilymphocyte Serum--therapeutic use<br/>Busulfan--therapeutic use<br/>Child<br/>Child, Preschool<br/>Female<br/>Graft Rejection--etiology<br/>Graft vs Host Disease--prevention & control<br/>Humans<br/>Male<br/>Middle Aged<br/>Stem Cell Transplantation--adverse effects<br/>Transplantation Chimera--immunology<br/>Transplantation Conditioning--methods<br/>Transplantation, Homologous<br/>Vidarabine--analogs & derivatives<br/>beta-Thalassemia--therapy